GSK plc Announces Dividend of GBX 15 (LON:GSK)

GSK plc (LON:GSK) declared a dividend on Wednesday, May 1st, Upcoming.Co.Uk reports. Shareholders of record on Thursday, May 16th will be given a dividend of GBX 15 ($0.19) per share on Thursday, July 11th. This represents a yield of 0.9%. The ex-dividend date is Thursday, May 16th. The official announcement can be viewed at this link.

GSK Price Performance

GSK stock opened at GBX 1,716 ($21.56) on Thursday. GSK has a 1 year low of GBX 1,302.60 ($16.36) and a 1 year high of GBX 1,719.80 ($21.60). The company has a debt-to-equity ratio of 140.82, a current ratio of 0.88 and a quick ratio of 0.73. The firm has a market capitalization of £70.18 billion, a PE ratio of 1,420.83, a price-to-earnings-growth ratio of 1.12 and a beta of 0.27. The business has a 50 day simple moving average of GBX 1,660.86 and a 200-day simple moving average of GBX 1,555.08.

Analyst Ratings Changes

GSK has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 1,950 ($24.49) price objective on shares of GSK in a report on Wednesday, April 17th. Barclays reissued an “equal weight” rating and issued a GBX 1,725 ($21.67) price target on shares of GSK in a research note on Monday, April 8th. Shore Capital reaffirmed a “buy” rating on shares of GSK in a research report on Wednesday. Finally, Berenberg Bank increased their price objective on GSK from GBX 1,650 ($20.73) to GBX 1,820 ($22.86) and gave the stock a “buy” rating in a research report on Wednesday, February 14th. One analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of GBX 1,630.63 ($20.48).

Insider Activity at GSK

In other GSK news, insider Emma Walmsley sold 139,792 shares of GSK stock in a transaction on Friday, February 16th. The shares were sold at an average price of GBX 1,658 ($20.83), for a total value of £2,317,751.36 ($2,911,382.19). In other news, insider Emma Walmsley sold 139,792 shares of the firm’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of GBX 1,658 ($20.83), for a total value of £2,317,751.36 ($2,911,382.19). Also, insider Urs Rohner acquired 434 shares of GSK stock in a transaction that occurred on Wednesday, March 20th. The stock was purchased at an average price of GBX 1,662 ($20.88) per share, with a total value of £7,213.08 ($9,060.52). Insiders own 1.77% of the company’s stock.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.